COVID-19-Related Brief Insomnia in a 13-Year-Old Adolescent Girl.
Sleep Sci
; 17(1): e112-e114, 2024 Mar.
Article
em En
| MEDLINE
| ID: mdl-38545246
ABSTRACT
Neuropsychiatric manifestations that have developed after coronavirus disease 2019 (COVID-19) infection have not been fully clarified yet. Persistent insomnia and consequent significant impairment in daily functioning is an unexpected symptom of COVID-19 infection. In this case report, a 13-year-old female patient who presented with complaint of insomnia starting with COVID-19 infection is discussed. The patient showed significant improvement with melatonin treatment and maintained her wellbeing in the follow-up. Melatonin may be a useful option to treat COVID-19-related brief insomnia in adolescents. Our case report will be a step forward to help clinicians examine the underlying neurovegetative mechanisms, such as sleep, to improve patients wellbeing. HEADINGS COVID-19. Melatonin. Sleep Initiation and Maintenance Disorders.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Sleep Sci
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Turquia